(IMMU) |
| 0 (0%) 08-22 20:38 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 12.08 |
| Resistance 1: | 10.34 |
| Pivot price: | 10.14 |
| Support 1: | 10.12 |
| Support 2: | 9.98 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.950 |
| Book Value | 10.980 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.707 |
| Profit Margin (%) | 134.48 |
| Operating Margin (%) | 78.28 |
| Return on Assets (ttm) | 2.1 |
| Return on Equity (ttm) | 8.8 |
Company news
Thu, 20 Aug 2026
IMMU: Positive AML survival data, strong safety, and expanding pipeline with solid cash runway - TradingView
Thu, 20 Aug 2026
IMMU: Advancing AML and CML trials, reducing costs, and preparing for U.S. pediatric expansion - TradingView
Fri, 26 Jun 2026
Health: Govt warns parents risk jail for skipping child immu - NewVision.co.ug
Thu, 25 Jun 2026
FDA Approval for TRODELVY issued to IMMUNOMEDICS INC - Quantisnow
Tue, 27 Jan 2026
T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases - Nature
Tue, 11 Nov 2025
Fuzon comes back after six years with new vocalist - The Express Tribune
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
